Natco Pharma Ltd - Stock Price

As on17 Sep 2021
  • BSE : 524816
  • ISIN CODE : INE987B01026
  • Industry : Pharmaceuticals & Drugs
  • House : Natco
Natco Pharma Ltd is not traded on BSE/NSE
-3.07 %-29.7
-2.52 %-24.4

Profit & Loss

Parameter MAR 21  MAR 20  YoY %Change
Gross Sales20840.0020582.001.25
     Job Work/ Contract Receipts101.00302.00-66.56
     Processing Charges / Service Income153.001451.00-89.46
     Revenue from property developmentNANANA
     Other Operational Income3618.00272.001230.15
Less: Excise DutyNANANA
Net Sales20521.0019150.007.16
Increase/Decrease in Stock-481.00-752.0036.04
Raw Material Consumed5318.004296.0023.79
     Opening Raw Materials1601.002107.00-24.02
     Purchases Raw Materials5222.002512.00107.88
     Closing Raw Materials3371.001601.00110.56
     Other Direct Purchases / Brought in cost1866.001278.0046.01
     Other raw material cost0.000.000.00
Power & Fuel Cost611.00624.00-2.08
     Electricity & Power611.00624.00-2.08
     Oil, Fuel & Natural gas0.000.000.00
     Coals etc0.000.000.00
     Other power & fuel0.000.000.00
Employee Cost4149.003750.0010.64
     Salaries, Wages & Bonus3530.003129.0012.82
     Contributions to EPF & Pension Funds238.00223.006.73
     Workmen and Staff Welfare Expenses139.00151.00-7.95
     Other Employees Cost242.00247.00-2.02
Other Manufacturing Expenses2919.002433.0019.98
     Sub-contracted / Out sourced servicesNANANA
     Processing ChargesNANANA
     Repairs and Maintenance544.00510.006.67
     Packing Material Consumed277.00272.001.84
     Other Mfg Exp2098.001651.0027.07
General and Administration Expenses1167.001326.00-11.99
     Rent , Rates & Taxes370.00399.00-7.27
     Printing and stationeryNANANA
     Professional and legal fees298.00356.00-16.29
     Traveling and conveyance162.00256.00-36.72
     Other Administration300.00424.00-29.25
Selling and Distribution Expenses344.00981.00-64.93
     Advertisement & Sales Promotion211.00936.00-77.46
     Sales Commissions & IncentivesNANANA
     Freight and Forwarding133.0045.00195.56
     Handling and Clearing Charges0.000.000.00
     Other Selling Expenses0.000.000.00
Miscellaneous Expenses432.00666.00-35.14
     Bad debts /advances written off117.0055.00112.73
     Provision for doubtful debtsNANANA
     Losson disposal of fixed assets(net)NANANA
     Losson foreign exchange fluctuationsNANANA
     Losson sale of non-trade current investmentsNANANA
     Other Miscellaneous Expenses315.00611.00-48.45
Less: Expenses CapitalisedNANANA
Total Expenditure14459.0013324.008.52
Operating Profit (Excl OI)6062.005826.004.05
Other Income1036.001074.00-3.54
     Interest Received566.00791.00-28.45
     Dividend ReceivedNANANA
     Profit on sale of Fixed Assets320.00163.0096.32
     Profits on sale of InvestmentsNANANA
     Provision Written BackNA29.00NA
     Foreign Exchange Gains40.0051.00-21.57
Operating Profit7098.006900.002.87
     InterestonDebenture / BondsNANANA
     Interest on Term LoanNANANA
     Intereston Fixed depositsNANANA
     Bank Charges etc45.0038.0018.42
     Other Interest88.00177.00-50.28
Profit Before Taxation & Exceptional Items5796.005687.001.92
Exceptional Income / ExpensesNANANA
Profit Before Tax5796.005687.001.92
Provision for Tax1372.001106.0024.05
     Current Income Tax1408.001271.0010.78
     Deferred Tax144.00177.00-18.64
     Other taxes108.0012.00800.00
Profit After Tax4424.004581.00-3.43
Extra itemsNANANA
Minority Interest-15.0027.00-155.56
Share of AssociateNANANA
Other Consolidated ItemsNANANA
Consolidated Net Profit4409.004608.00-4.32
Adjustments to PATNANANA
Profit Balance B/F22391.0019371.0015.59
     General ReservesNANANA
     Proposed Equity DividendNANANA
     Corporate dividend taxNA215.00NA
     Other Appropriation160.00144.0011.11
Equity Dividend %263.00338.00-22.19
Earnings Per Share24.0025.00-4.00
Adjusted EPS24.0025.00-4.00

About Natco Pharma Ltd.

Natco Pharma Ltd. was incorporated in the year 1981. Its today's share price is 942.2. Its current market capitalisation stands at Rs 17179.87 Cr. In the latest quarter, company has reported Gross Sales of Rs. 16854 Cr and Total Income of Rs.17546 Cr. The company's management includes M Adinarayana, Sridhar Sankararaman, D Linga Rao, MUR Naidu, PSRK Prasad, Leela Digumarti, DG Prasad, Rajeev Nannapaneni, TV Rao, G S Murthy, V C Nannapaneni, V C Nannapaneni.

It is listed on the BSE with a BSE Code of 524816 , NSE with an NSE Symbol of NATCOPHARM and ISIN of INE987B01026. It's Registered office is at Natco House,Road No 2,Banjara HillsHyderabad-500003, Telangana. Their Registrars are ACC Ltd. It's auditors are Brahmayya & Co, BSR & Associates LLP, Walker Chandiok & Co LLP, Walker, Chandiok & Co, Walker, Chandiok & Co LLP

Latest News